683 Capital Management »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by 683 Capital Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 1.0M 1.35

More positions owned by 683 Capital Management

Eli Lilly & Co. Put Option (LLY)
Tesla Motors Call Option (TSLA)
Capital One Financial (COF)
Hilton Grand Vacations (HGV)
Sharkninja Com Shs (SN)
Ero Copper Corp (ERO)
BorgWarner (BWA)
Carvana Cl A (CVNA)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Moderna (MRNA)
Alnylam Pharmaceuticals Put Option (ALNY)
Wave Life Sciences SHS (WVE)
Tg Therapeutics (TGTX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Insmed Note 0.750% 6/0 (Principal)

View all positions for 683 Capital Management

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Wolverine Asset Management
Readystate Asset Management
MacKay Shields
Franklin Resources
Advent Capital Management
Point72 Asset Management
SSI Investment Management
BlackRock
Jpmorgan Chase & Co
Tang Capital Management
Kornitzer Capital Management
Bnp Paribas Arbitrage, Snc
New York State Common Retirement Fund
Citigroup

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0